Clinical trial
Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)
NCT00092560 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00092560 |
|---|---|
| Title | Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036) |
| Official title | Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Hypertriglyceridemia |
| Intervention type | Drug |
| Interventions | MK0653, ezetimibe, Comparator: fenofibrate monotherapy |
| Enrollment | 587 |
| Start date | Dec 1, 2002 |
| Primary completion | Dec 1, 2003 |
| Completion | Dec 1, 2003 |
| First posted | Sep 28, 2004 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: